TORIE LESLIE: Open Payments
NPI 1407411275 · MARYSVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,011 in 105 payments from 20 companies in 2025. Trend: 2023 $1,112 · 2024 $1,470 · 2025 $2,011
Food & beverage: $2,011
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $297 |
| AstraZeneca Pharmaceuticals LP | 13 | $290 |
| Vanda Pharmaceuticals Inc. | 11 | $271 |
| ABBVIE INC. | 10 | $238 |
| Axsome Therapeutics, Inc. | 9 | $170 |
| Amgen Inc. | 13 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Lilly USA, LLC | 4 | $64 |
Products named: FANAPT, Auvelity, QULIPTA, Wegovy, Ozempic, FARXIGA, OTEZLA, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
